TY - JOUR
T1 - Exploration of copper-cysteamine nanoparticles as a new type of agents for antimicrobial photodynamic inactivation
AU - Huang, Liyi
AU - Ma, Lun
AU - Xuan, Weijun
AU - Zhen, Xiumei
AU - Zheng, Han
AU - Chen, Wei
AU - Hamblin, Michael R.
N1 - Publisher Copyright:
© 2019 American Scientific Publishers.
PY - 2019
Y1 - 2019
N2 - Copper-cysteamine (Cu-Cy) nanoparticles (NPs) are a new type of sensitizers that can be activated by UV light, X-rays, microwaves and ultrasound to produce reactive oxygen species for cancer treatment. Here, for the first time, we explored Cu-Cy NPs for bacteria inactivation by treating gram-positive bacteria (methicillin-resistant Staphylococcus aureus and Enterococcus faecalis) and gram-negative bacteria (Escherichia coli and Acinetobacter baumannii), respectively. The results show that Cu-Cy NPs are very effective in killing gram-positive bacteria but are quite limited in killing gram-negative bacteria yet. The major killing mechanism is cell damage by singlet oxygen and Cu-Cy NPs are potential agents for bacteria inactivation.
AB - Copper-cysteamine (Cu-Cy) nanoparticles (NPs) are a new type of sensitizers that can be activated by UV light, X-rays, microwaves and ultrasound to produce reactive oxygen species for cancer treatment. Here, for the first time, we explored Cu-Cy NPs for bacteria inactivation by treating gram-positive bacteria (methicillin-resistant Staphylococcus aureus and Enterococcus faecalis) and gram-negative bacteria (Escherichia coli and Acinetobacter baumannii), respectively. The results show that Cu-Cy NPs are very effective in killing gram-positive bacteria but are quite limited in killing gram-negative bacteria yet. The major killing mechanism is cell damage by singlet oxygen and Cu-Cy NPs are potential agents for bacteria inactivation.
KW - Antimicrobial photodynamic inactivation
KW - Copper-cysteamine nanoparticles
KW - Gram-negative bacteria
KW - Gram-positive bacteria
KW - Reactive oxygen species
UR - http://www.scopus.com/inward/record.url?scp=85071638580&partnerID=8YFLogxK
U2 - 10.1166/jbn.2019.2829
DO - 10.1166/jbn.2019.2829
M3 - Article
C2 - 31462378
AN - SCOPUS:85071638580
SN - 1550-7033
VL - 15
SP - 2142
EP - 2148
JO - Journal of Biomedical Nanotechnology
JF - Journal of Biomedical Nanotechnology
IS - 10
ER -